Related Experiment Videos

[Problems of antibiotic-resistance Gram negative pathogens in the hospital environment]

N Liassine1

  • 1Laboratoire central de bactériologie, Hôpital Cantonal Universitaire, 25, rue Micheli-du-Crest CH-1211 Genève 4. nadia.liassine@hcuge.ch

Schweizerische Medizinische Wochenschrift
|February 24, 2001
PubMed

Insights

Hospital-acquired Gram-negative pathogens exhibit intrinsic and acquired resistance, driving their selection. Combating antimicrobial resistance requires collaboration among clinicians, microbiologists, and infection control teams.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Context:

  • Gram-negative pathogens like Enterobacteriaceae, Pseudomonas, Acinetobacter, and Stenotrophomonas are prevalent in hospitals.
  • These bacteria possess intrinsic resistance and rapidly acquire new resistance mechanisms.
  • The selection and dissemination of these resistant strains pose significant challenges in healthcare settings.

Purpose:

  • To highlight the mechanisms of resistance in Gram-negative hospital pathogens.
  • To underscore the difficulties in managing and controlling the spread of multidrug-resistant bacteria.
  • To emphasize the need for a multidisciplinary approach to combat antimicrobial resistance.

Summary:

  • Gram-negative pathogens in hospitals display inherent and acquired resistance, contributing to their prevalence.
  • Resistance spreads through clonal dissemination or horizontal gene transfer among bacterial species.
  • Detecting resistance, such as extended-spectrum beta-lactamase production, and managing infections caused by multidrug-resistant organisms are complex clinical and microbiological issues.

Impact:

  • Effective management of hospital-acquired infections necessitates a coordinated strategy involving clinical, microbiological, and infection control expertise.
  • Addressing the complexity of bacterial resistance requires integrated efforts to preserve antibiotic efficacy.
  • Improved detection and control measures are crucial to mitigate the impact of multidrug-resistant Gram-negative pathogens.

Related Concept Videos